Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI)

CAPS Rating: 1 out of 5

The Company is engaged in developing, implementing and licensing scientific technology for the curing of tobacco and also manufactures, markets and develops very low-nitrosamine smokeless tobacco products and selling of discount cigarettes.

Recs

0
Player Avatar pchop123 (80.21) Submitted: 11/16/2012 1:45:42 PM : Underperform Start Price: $1.75 RCPI Score: -46.00

time to take money off the table

Featured Broker Partners


Advertisement